Updated pregnancy outcomes from the teriflunomide clinical development programme: retrospective analysis of the teriflunomide clinical trial database

被引：0
|
作者：
Kieseier, B. [1 ]
Stueve, O. [2 ]
Benamor, M. [3 ]
Delhay, J. [3 ]
Truffinet, P. [3 ]
机构：
[1] Univ Dusseldorf, Dusseldorf, Germany
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Sanofi, Chilly Mazarin, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：223 / 224
页数：2
相关论文
共 50 条
  • [11] Clinical and MRI Outcomes from a Phase III Trial (TEMSO) of Oral Teriflunomide in Multiple Sclerosis with Relapses
    Miller, Aaron
    O'Connor, Paul
    Wolinsky, Jerry S.
    Confavreux, Christian
    Comi, Giancarlo
    Kappos, Ludwig
    Olsson, Tomas P.
    Benzerdjeb, Hadj
    Truffinet, Philippe
    Wang, Lin
    Freedman, Mark S.
    NEUROLOGY, 2011, 76 (09) : A545 - A545
  • [12] Pregnancy outcomes in patients with MS treated with teriflunomide: clinical study and post-marketing data
    Vukusic, S.
    Coyle, P. K.
    Jurgensen, S.
    Truffinet, P.
    Benamor, M.
    Chambers, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 63 - 64
  • [13] Long-term Clinical and MRI Outcomes From Teriflunomide Extension Studies
    Vucic, S.
    Parratt, J.
    Li, D. K. B.
    Macdonell, R.
    King, J.
    Truffinet, P.
    Dukovic, D.
    O'Connor, P. W.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 821 - 821
  • [14] Outcomes of the TEMSO extension study of teriflunomide: 10.5 years of clinical results
    Freedman, M. S.
    Miller, A. E.
    Comi, G.
    Kappos, L.
    LeBrun-Frenay, C.
    Truffinet, P.
    Purvis, A.
    Benamor, M.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 334 - 335
  • [15] Magnetic resonance imaging outcomes from a phase III trial of teriflunomide
    Wolinsky, Jerry S.
    Narayana, Ponnada A.
    Nelson, Flavia
    Datta, Sushmita
    O'Connor, Paul
    Confavreux, Christian
    Comi, Giancarlo
    Kappos, Ludwig
    Olsson, Tomas P.
    Truffinet, Philippe
    Wang, Lin
    Miller, Aaron
    Freedman, Mark S.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1310 - 1319
  • [16] Clinical outcomes in patients with faster advancing MS treated with teriflunomide in TEMSO and TOWER
    Kappos, L.
    Thangavelu, K.
    Cavalier, S.
    Truffinet, P.
    Comi, G.
    Miller, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 197 - 197
  • [17] Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome The TERIS Randomized Clinical Trial
    Lebrun-Frenay, Christine
    Siva, Aksel
    Sormani, Maria Pia
    Landes-Chateau, Cassandre
    Mondot, Lydiane
    Bovis, Francesca
    Vermersch, Patrick
    Papeix, Caroline
    Thouvenot, Eric
    Labauge, Pierre
    Durand-Dubief, Francoise
    Efendi, Husnu
    Le Page, Emmanuelle
    Terzi, Murat
    Derache, Nathalie
    Bourre, Bertrand
    Hoepner, Robert
    Karabudak, Rana
    De Seze, Jerome
    Ciron, Jonathan
    Clavelou, Pierre
    Wiertlewski, Sandrine
    Turan, Omer Faruk
    Yucear, Nur
    Cohen, Mikael
    Azevedo, Christina
    Kantarci, Orhun H.
    Okuda, Darin T.
    Pelletier, Daniel
    TERIS Study Grp
    JAMA NEUROLOGY, 2023,
  • [18] Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial
    Lebrun-Frenay, Christine
    Siva, Aksel
    Sormani, Maria Pia
    Landes-Chateau, Cassandre
    Mondot, Lydiane
    Bovis, Francesca
    Vermersch, Patrick
    Papeix, Caroline
    Thouvenot, Eric
    Labauge, Pierre
    Durand-Dubief, Francoise
    Efendi, Husnu
    Le Page, Emmanuelle
    Terzi, Murat
    Derache, Nathalie
    Bourre, Bertrand
    Hoepner, Robert
    Karabudak, Rana
    De Seze, Jerome
    Ciron, Jonathan
    Clavelou, Pierre
    Wiertlewski, Sandrine
    Turan, Omer Faruk
    Yucear, Nur
    Cohen, Mikael
    Azevedo, Christina
    Kantarci, Orhun H.
    Okuda, Darin T.
    Pelletier, Daniel
    JAMA NEUROLOGY, 2023, 80 (10) : 1080 - 1088
  • [19] Clinical and Safety Outcomes From Patients Treated With Teriflunomide in the Phase 4 Teri-PRO Study
    Gold, Ralf
    Khatri, Bhupendra
    Edwards, Keith R.
    Lallana, Jose Meca
    Cavalier, Steve
    Rufi, Pascal
    Benamor, Myriam
    Brette, Sandrine
    Chowdhury, Somankumar
    Coyle, Patricia K.
    NEUROLOGY, 2017, 88
  • [20] Long-Term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials
    Macdonell, R.
    Freedman, M. S.
    Ramio-Torrenta, L.
    Zaffaroni, M.
    De Seze, J.
    Ahn, S.
    Miller, A. E.
    Kallmann, B.
    Rog, D.
    Benamor, M.
    Truffinet, P.
    Chavin, J.
    Poole, E.
    Lebrun-Frenay, C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 472 - 473
12345